A rigorous, real-world clinical trial designed to generate publishable evidence on dementia intervention.
Do brain stimulation activities and nutritionally dense food slow the progression of dementia as measured by cognitive language assessments?
Trials are hosted at partner care homes on a weekly basis. The care home provides space and access to participants; Captain’s Chair provides the platform, the meal, and the research protocol.
Change in cognitive language expression on a validated picture description task, assessed at baseline, midpoint, and end of trial.
Memory recall, verbal fluency, mood, and caregiver-reported quality of life. Dietary compliance data is correlated with cognitive assessment outcomes.
All collected data will be submitted for independent academic review, providing a pathway to peer-reviewed publication and establishing credibility with grant bodies.
All assessment tools are grounded in peer-reviewed literature and validated for use in dementia research.
The foundational picture description paradigm for our cognitive assessment engine. Participants describe a scene verbally; our technology analyzes their language over time to track changes in cognitive expression.
A widely validated screening tool for mild cognitive impairment. Administered at baseline and end of trial to provide a standardized, comparable measure of overall cognitive function.
Phonemic and semantic fluency tasks that measure executive function and language retrieval — areas particularly sensitive to early-stage dementia progression.
Standardized mood and quality-of-life measures completed by participants and reported by caregivers, capturing the broader impact of the intervention beyond cognitive performance alone.
There is limited existing evidence on combined nutrition and cognitive stimulation interventions — particularly in real-world care settings rather than controlled laboratory environments.
Captain’s Chair is designed to fill that gap with credible, publishable clinical data collected in actual care homes from community members with early-stage dementia who might not otherwise have access to structured research programs.
The trial’s real-world setting, rigorous methodology, and partnerships with established care homes make it both scientifically credible and fundable.
CIHR — Canadian Institutes of Health Research
Primary federal health research funder
ASRP — Alzheimer Society Research Program
Dementia-specific research grants
AGE-WELL NCE
Aging and technology research network
Ontario Brain Institute
Ontario-based neuroscience and dementia research